isopentenyl pyrophosphate has been researched along with pamidronate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gossman, W; Oldfield, E | 1 |
| Agrati, C; Casetti, R; Gougeon, ML; Malkovsky, M; Poccia, F | 1 |
| Belardelli, F; Cardone, M; Casetti, R; Conti, L; Gessani, S; Martino, A; Poccia, F; Varano, B | 1 |
| Casetti, R; Colizzi, V; D'Offizi, G; Dieli, F; Malkovsky, M; Mattei, M; Perretta, G; Poccia, F; Taglioni, A | 1 |
| Feng, T; Gong, T; Li, M; Miao, T; Wan, L; Wang, Y; Xi, Y | 1 |
| Casasnovas, R; Fernández, D; Frau, J; Ortega-Castro, J; Ramis, R; Vilanova, B | 1 |
1 review(s) available for isopentenyl pyrophosphate and pamidronate
| Article | Year |
|---|---|
Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?
Topics: Adjuvants, Immunologic; Antigen Presentation; Antiretroviral Therapy, Highly Active; Chemokines; Diphosphonates; Hemiterpenes; HIV Infections; Humans; Immunity, Cellular; Immunity, Innate; Immunotherapy; Lymphocyte Activation; Lymphokines; Models, Immunological; Mucous Membrane; Organophosphorus Compounds; Pamidronate; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Receptors, Immunologic; Receptors, Natural Killer Cell; T-Lymphocyte Subsets | 2002 |
5 other study(ies) available for isopentenyl pyrophosphate and pamidronate
| Article | Year |
|---|---|
Quantitative structure--activity relations for gammadelta T cell activation by phosphoantigens.
Topics: Antigens, Bacterial; Lymphocyte Activation; Models, Molecular; Phosphoproteins; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes | 2002 |
Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines.
Topics: Anti-Inflammatory Agents; Antigens, CD; B7-2 Antigen; Cell Communication; Cytokines; Dendritic Cells; Diphosphonates; Hemiterpenes; Histocompatibility Antigens Class I; Humans; Inflammation; Interferon-gamma; Lymphocyte Activation; Membrane Glycoproteins; Organophosphorus Compounds; Pamidronate; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2005 |
Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2.
Topics: 2,3-Diphosphoglycerate; Animals; Antigens; CD4-CD8 Ratio; Cell Differentiation; Cell Proliferation; Cells, Cultured; Diphosphates; Diphosphonates; Epoxy Compounds; Hemiterpenes; Immunologic Memory; Injections, Intravenous; Injections, Subcutaneous; Interferon-gamma; Interleukin-2; Macaca fascicularis; Organophosphorus Compounds; Pamidronate; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Th1 Cells | 2005 |
[Amplification efficency and optimization of culture conditions of γδ T cells in peripheral blood by different phosphate compounds].
Topics: Anti-Inflammatory Agents; Cell Proliferation; Cells, Cultured; Diphosphonates; Dose-Response Relationship, Drug; Flow Cytometry; Hemiterpenes; Humans; Interleukin-2; Leukocytes, Mononuclear; Organophosphorus Compounds; Pamidronate; Phosphates; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Time Factors | 2014 |
New insights into human farnesyl pyrophosphate synthase inhibition by second-generation bisphosphonate drugs.
Topics: Alendronate; Binding Sites; Bone Density Conservation Agents; Diphosphonates; Drug Discovery; Geranyltranstransferase; Hemiterpenes; Humans; Molecular Dynamics Simulation; Organophosphorus Compounds; Pamidronate; Protein Binding; Structure-Activity Relationship; Thermodynamics | 2017 |